Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Survey Flushes Out The Secrets Of Americans' Bathroom Habits
Whether it"s "powdering your nose" or settling in for a good read, Americans spend a significant amount of time in the bathroom. According to a recent Yankelovich survey, many Americans spend more than 30 minutes each day in the bathroom that adds up to nearly eight days each year - which is more than double that of the average vacation trip . And contrary to popular belief, men spend almost as much time in the bathroom as women.
generic viagra online
Behavioral Effects Of Addiction Enhanced By Cocaine-Linked Genes
New research sheds light on how cocaine regulates gene expression in a crucial reward region of the brain to elicit long-lasting changes in behavior. The study, published by Cell Press in the May 14th issue of the journal Neuron, provides exciting insight into the molecular pathways regulated by cocaine and may lead to new strategies for battling drug addiction.
News of the day
Manchester Clinical Psychologist Wins May Davidson Award, UK
Dr Sam Cartwright-Hatton from the University of Manchester has won this year"s May Davidson Award. The award is made each year by the British Psychological Society"s Division of Clinical Psychology to someone who has made an outstanding contribution to the development of clinical psychology within the first 10 years of their career.
Endocrinology

Prevalence Of Artemisinin Monotherapies Raising Risk Of Resistence

Almost half of all artemisinin manufacturers and malaria-endemic countries are "failing to comply" with WHO requirements to sell the treatment in combination with other drugs, which is increasing the risk that malaria parasites will develop resistance to artemsinin, Nature reports. "Of the 69 manufacturers of artemisinin monotherapies that the WHO has identified, 21 have withdrawn monotherapies, and 14 say they intend to comply with the WHO"s recommendations. But the remaining 34 have not yet disclosed their intentions," Nature writes. Andrea Bosman, an official at the WHO"s Global Malaria Program, said, many manufacturers have not replied to multiple WHO requests for information. In addition, regulatory authorities in 39 of the 76 countries using malaria drugs have either complied or said they intend to comply with the WHO"s recommendations. "Artemisinin and its derivatives are the leading treatments for the disease" and are the only malaria drugs "that have not yet seen widespread resistance in malaria parasites," writes Nature. The WHO will soon publish a briefing about the full scope of the problem and will call for "governments to empower national drug-regulatory authorities to clamp down on offending companies," according to Nature. In January 2006, the WHO recommended that artemisinin be given in combination with other drugs for at least three days to reduce the chances of resistance. Now the need to move away from monotherapies has become "all the more urgent" with recent reports of resistance arising in Cambodia, Nature reports (Butler, 7/14). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009